FP
Flagship Pioneering Portfolio holdings
AUM
$268M
This Quarter Return
+33.84%
1 Year Return
-54.4%
3 Year Return
-51.2%
5 Year Return
+66.7%
10 Year Return
–
AUM
$299M
AUM Growth
+$299M
(+5.4%)
Cap. Flow
-$64.4M
Cap. Flow
% of AUM
-21.55%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
2
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Editas Medicine
EDIT
|
$40.9M |
| 2 |
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
|
$23.6M |
Sector Composition
| 1 | Healthcare | 97.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Seres Therapeutics
MCRB
$166M
| $203M | 68.04% |
12,682,876
| – | – |
|
|
SYRS
2
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $47.2M | 15.78% |
3,204,437
-1,602,219
| -33% | -$23.6M |
|
|
3
Editas Medicine
EDIT
$231M
| $40.2M | 13.45% |
1,674,435
-1,701,749
| -50% | -$40.9M |
|
|
TTOO
4
DELISTED
T2 Biosystems, Inc
TTOO
| $8.19M | 2.74% |
1,950,583
| – | – |
|